Detection of Human Papillomavirus in biopsies of patients with cervical cancer, and its association with prognosis

Archives of Gynecology and Obstetrics

Volumn 288, Issue 3, 2013, Pages 643-648

  Barreto, Carla Limeira ^a,c   Martins, Danyelly Bruneska Gondim ^b   De Lima Filho, José Luiz ^b   Magalhães, Vera ^b  

^a Hospital Universitario Oswaldo Cruz   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c NONE   (Brazil)

Author keywords

HPV; Invasive cervical cancer; PCR; Prognosis

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; POLYMERASE CHAIN REACTION; SURVIVAL RATE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; VIRUS IDENTIFICATION; WART VIRUS;

BRAZIL; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PROGNOSIS; UTERINE CERVICAL NEOPLASMS;

EID: 84882602958     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-2803-2     Document Type: Article

References (21)

1. Agência Internacional para Pesquisa do Câncer (2008) Estatística global do câncer, Organização Mundial da Saúde. http://globocan.iarc.fr/factsheet.asp. Accessed 10 Jan 2012
2. Instituto Nacional de Câncer José de Alencar Gomes da Silva (2011) Estimativa 2012: Incidência de Câncer no Brasil. Ministério da Saúde. http://inca.gov.br/estimativa/2012/ estimativa20122011.pdf. Accessed 10 Jan 2012
3. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJL, Naghavi M (2011) Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 378:1461-1484
4. Federação Brasileira das Sociedades de Ginecologia e Obstetrícia (2002) Papilomavírus Humano (HPV): Diagnóstico e Tratamento. http://www.febrasgo.org.br/arquivos/diretrizes/079.pdf. Accessed 16 June 2010
5. Hellner K, Munger K (2011) Human Papillomaviruses as therapeutic targets in human cancer. J Clin Oncol 29:1785-1794
6. Ho GYF, Bierman R, Beardsley NP, Chang CJ, Burk RD (1998) Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338(7):423-428
7. Higgins GD, Uzelin DM, Philips GE, Davy M, Roder D, Burrell CJ (1991) Increased age and mortality associated with cervical carcinomas negative for human papillomavirus. Lancet 338(8772):910-913
8. Riou G, Bourhis J, Favre M, Orth G, Jeannel D, Le Doussal V (1990) Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet 335(8699):1171-1174
9. Eifel PJ, Berek JS, Markman M (2011) Cancer of the cervix, vagina, and vulva. In: Devita VT Jr, Lawrence TS, Rosenberg SA (eds) Cancer principles and practice of oncology. Lippincott Williams and Wilkins, Philadelphia, pp 1311-1344
10. Ota T, Takeshima N, Tabata T, Hasumi K, Takizawa K (2007) Treatment of squamous cell carcinoma of the uterine cervix with radiation therapy alone: long-term survival, late complications, and incidence of second cancers. Brit J Cancer 97(8):1058-1062
11. Husman AMR, Walboomers JMM, van den Brule AJC, Meijer CJLM, Snijders PJF (1995) The use of general primers GP5 and GP elongated at their 3′ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76:1057-1062
12. + prime sets improves detection of HPV DNA in cervical samples. J Virol Methods 122:87-93
13. Khan S, Jaffer NN, Khan MN, Rai MA, Shafiq M, Ali A et al (2007) Human papillomavirus subtype 16 is common in Pakistani women with cervical carcinoma. IJID 11:313-317
14. Haie-Meder C, Morice P, Castiglione M (2010) Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(5s):37-40
15. Cooke SL, Temple J, MacArthur S, Zahra MA, Tan LT, Crawford RAF et al (2011) Intra-tumor genetic heterogeneity and poor chemoradiotherapy response in cervical cancer. B J Cancer 104:361-368
16. Howell-Jones R, Bailey A, Beddows S, Sargent A, Silva N, Wilson G et al (2010) Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England. BJC 103:209-216
17. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferency A et al (2007) Human Papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 357(16):1579-1588
18. Huang HJ, Huang SL, Lin CY, Lin RW, Chao FY, Chen MY et al (2004) Human papillomavirus genotyping by polymerase chain reaction-based genechip method in cervical carcinoma treated with neoadjuvant chemotherapy plus radical surgery. Int J Gynecol Cancer 14:639-649
19. Prétet JL, Jacquard AC, Carcopino X, Charlot JF, Bouhour D, Kantelip B et al (2007) Human Papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study. Int J Cancer 122:428-432
20. Huang LW, Chao SL, Hwang JL (2004) Human Papillomavirus-31-related types predict better survival in cervical carcinoma. Cancer 100(2):327-334
21. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML (2008) Improved survival for patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100:261-269